- Published at
- by gurufocus.com
positive
positive
News for Mirum Pharmaceuticals, Inc. (MIRM.MX)
- Published at
- by seekingalpha.com
positivepositiveMirum Pharmaceuticals, Inc. (MIRM) Q4 2024 Earnings Call Transcript
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ETCompany ParticipantsAndrew McKibben - Senior Vice...- Published at
- by insidermonkey.com
mixedmixed10 Best Performing Mid Cap Stocks to Buy According to Analysts
On February 7, Simeon Hyman, Global Investment Strategist at ProShares Advisors, appeared on CNBC to discuss the upcoming jobs report and its expected impact on the market.- Published at
- by gurufocus.com
positivepositiveFDA Approves Mirum Pharmaceuticals' CTEXLI for Rare Disease Treatment
Mirum Pharmaceuticals Inc (MIRM) announced on [date of press release] that the U.S. Food and Drug Administration (FDA) has approved CTEXLIâ„¢ (chenodiol) tablet- Published at
- by gurufocus.com
positivepositiveMirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved CTEXLIâ„¢ (chenodiol) tablets, a bile- Published at
- by gurufocus.com
positivepositiveTANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Acelyrin Inc
On February 18, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 5,298,328 shares of Acelyrin Inc. This acqu- Published at
- by gurufocus.com
positivepositiveTANG CAPITAL MANAGEMENT LLC's Strategic Acquisition of Galapagos NV Shares
On February 7, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant transaction by acquiring 4,210,525 shares of Galapagos NV. This acqu- Published at
- by gurufocus.com
positivepositiveJANUS HENDERSON GROUP PLC's Strategic Acquisition of Mirum Pharmaceuticals Shares
On December 31, 2024, JANUS HENDERSON GROUP PLC (Trades, Portfolio) executed a significant transaction by acquiring an additional 12,642,279 shares of Mirum Pha- Published at
- by gurufocus.com
mixedmixedEventide Asset Management, LLC Reduces Stake in Mirum Pharmaceuticals Inc
On December 31, 2024, Eventide Asset Management, LLC executed a significant transaction involving Mirum Pharmaceuticals Inc. The firm reduced its holdings by se- Published at
- by prweb.com
positivepositiveGenomenon and Mirum Pharmaceuticals Join Forces to Enhance CTX Disease Awareness and Diagnosis
/PRNewswire-PRWeb/ -- Genomenon, Inc., a leading provider of genomic intelligence solutions, has announced a strategic partnership with Mirum Pharmaceuticals,...- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveMetagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency Platfo- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
mixedmixed- Published at
- by gurufocus.com
positivepositiveMirum Pharmaceuticals Inc (MIRM) Announces Inducement Awards for New Employees
Mirum Pharmaceuticals Inc (MIRM), a biopharmaceutical company focused on treating rare diseases, announced on January 10, 2025, that its Compensation Committee- Published at
- by investing.com
positivepositiveMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) By Investing.com
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)- Published at
- by gurufocus.com
positivepositiveMirum Pharmaceuticals Inc (MIRM) to Present at J.P. Morgan Healthcare Conference
Mirum Pharmaceuticals Inc (MIRM), a biopharmaceutical company specializing in therapies for rare and orphan diseases, announced its participation in the 43rd An- Published at
- by gurufocus.com
positivepositiveMirum Pharmaceuticals Announces Inducement Awards for New Employees
Mirum Pharmaceuticals Inc (MIRM) announced on December 10, 2024, that its Compensation Committee has granted inducement awards to five new employees. These awar- Published at
- by gurufocus.com
positivepositiveMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on December 10, 2024, the Compensation Committee of Mirum's Board of Directors granted induceme- Published at
- by rttnews.com
mixedmixedBiotech Stocks Facing FDA Decision In December 2024
The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step into the final month of the year, let's take a look at the biotech companies whose drugs are under regulatory review in the U.